Skip to main content

Biodata Stage

Image

Biodata Stage

Harnessing the power of big data and analysis for better research outcomes

Harnessing the power of big data, this theatre will help you leverage the strategic growth of large-scale research datasets, their infrastructure and how to optimize the utility of big data across the globe to support research with deeper, richer analysis.

Loading
11:30
  1. Biodata Stage
    30 mins
    Scaling Big Genomics Data to Support Drug Development Strategy Modernising Genomic Data Management Strategies in Pharma Leveraging cutting-edge data science techniques to scale genomic and phenotype d ...
12:00
  1. Biodata Stage
    30 mins
      Scientific data (Multi-Omics, Spatial) is growing exponentially in size and complexity Biotechs need a scalable and intuitive platform to help R&D teams manage this data. Solution providers need to ...
12:30
  1. Biodata Stage
    30 mins
    Healthcare system-linked biobanks such as the VA Million Veteran Program have the opportunity to translate genomic discoveries directly to patient care This talk with give 2 examples of such work from ...
13:00
  1. Biodata Stage
    70 mins
14:10
  1. Biodata Stage
    30 mins
    Large scale multi-omics can empower drug discovery and development at every pipeline stage We talk, through several examples, how large biobank discoveries have shown novel disease insights that trans ...
14:40
  1. Biodata Stage
    30 mins
    Biopharma organizations generate vast and intricate omics datasets, creating significant challenges around data accessibility, usability, and the preservation of critical institutional knowledge. In t ...
15:10
  1. Biodata Stage
    30 mins
    This talk will demonstrate how to integrate large-scale tumor-derived and clinical genomic data sets to inform a data driven approach to cancer care.   Demonstrate novel methods to assess the actionab ...
15:40
  1. Biodata Stage
    30 mins
16:10
  1. Biodata Stage
    30 mins
    The GDC houses multi-omic and clinical data for > 44K cases, spanning 36 types of cancer across 86 projects. A cohort-centric interface allows integrated comparisons of patients with common features, ...
16:40
  1. Biodata Stage
    30 mins
    Growing scientific data complexity creates major challenges for interoperable storage and organizational access Successfully adopting AI/ML requires FAIR data principles: Findable, Accessible, Interop ...
17:10
  1. Biodata Stage
    30 mins
    In this presentation, we explore the genomic frontiers of Alzheimer’s research through the groundbreaking Alzheimer’s Disease Sequencing Project (ADSP) and the NIA Genetics of Alzheimer’s Disease Data ...
11:30
  1. Biodata Stage
    30 mins
    Results from largest APOE4 AD trial in patients treated with ALZ-801  Implementation of AlzheonNexus platform for analyzing clinical trial and real-world data
12:00
  1. Biodata Stage
    30 mins
    Key questions in drug discovery pipeline Key pieces that we can engineer to answer the key questions – one of them is data asset development and its untapped potential Data asset development – handlin ...
12:30
  1. Biodata Stage
    30 mins
    Accurate survival prediction in NSCLC remains a major clinical challenge due to the complexity of multi-omics and clinical data; integrating prior biological knowledge can enhance model interpretabili ...
13:00
  1. Biodata Stage
    50 mins
13:50
  1. Biodata Stage
    30 mins
    Population genetic screening involves systematically analyzing genetic variants across large groups to identify individuals at elevated risk for inherited conditions, thereby improving early detection ...
14:20
  1. Biodata Stage
    30 mins
    Prostate cancer is the most common cancer diagnosed in men, yet most men diagnosed with the disease will die of other causes Big data approaches are needed to conduct genetic epidemiological studies o ...
14:50
  1. Biodata Stage
    30 mins
    We'll discuss the importance of making multi-modal, real world cancer patient data available and interpretable to researchers and physician scientists and the requisite computational tools that are re ...